Medicare Enrolled

Dr. Asif Lakhani, M.D.

Internal Medicine · Webster, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
501 W MEDICAL CENTER BLVD, Webster, TX 77598
2813327505
In practice since 2011 (15 years)
NPI: 1932404779 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lakhani from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lakhani? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Lakhani

Dr. Asif Lakhani is an internal medicine specialist in Webster, TX, with 15 years of NPI registration. Based on federal Medicare data, Dr. Lakhani performed 74,153 Medicare services across 1,862 unique beneficiaries.

Between the years covered by Open Payments, Dr. Lakhani received a total of $2,400 from 48 pharmaceutical and/or device companies across 99 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Lakhani is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 15 years in practice ▲ Top 1% volume in TX $2,400 industry payments

Medicare Practice Summary

Medicare Utilization ↗
74,153
Medicare services
Top 1% in TX for internal medicine
1,862
Unique beneficiaries
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~4,944 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Iron infusion (Feraheme) 23,460 $0 $5
Pembrolizumab injection (Keytruda) 11,100 $43 $137
Anti-nausea injection (fosaprepitant) 9,900 $0 $5
Darbepoetin injection (Aranesp) for anemia 7,025 $2 $20
Iron sucrose injection (Venofer) 6,200 $0 $2
Contrast dye for imaging (iodine-based) 4,581 $0 $3
Paclitaxel chemotherapy injection 3,794 $0 $8
Dexamethasone injection (steroid) 1,353 $0 $1
Anti-nausea injection (Aloxi/palonosetron) 970 $1 $114
Injection, leucovorin calcium, per 50 mg 578 $3 $25
Blood draw (venipuncture) 566 $8 $20
Complete blood count (CBC) with differential 539 $8 $36
Comprehensive metabolic blood panel 519 $10 $64
Injection, fluorouracil, 500 mg 409 $2 $13
Office visit, established patient (30-39 min) 357 $92 $368
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less 312 $23 $157
Injection, granisetron hydrochloride, 100 mcg 270 $0 $24
Administration of chemotherapy into vein, 1 hour or less 220 $104 $707
Injection, carboplatin, 50 mg 206 $2 $300
Hospital follow-up visit, high complexity 177 $94 $357
Office visit, established patient, complex (40-54 min) 168 $137 $496
Hospital follow-up visit, moderate complexity 157 $61 $247
Injection of additional new drug or substance into vein 147 $12 $108
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 108 $51 $313
Drug injection, under skin or into muscle 104 $11 $96
Administration of chemotherapy into vein, each additional hour 97 $23 $161
Administration of additional new drug or substance into vein, 1 hour or less 94 $52 $344
Injection, zoledronic acid, 1 mg 73 $7 $431
Injection, diphenhydramine hcl, up to 50 mg 65 $1 $7
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle 61 $58 $211
Initial hospital admission, high complexity 55 $137 $694
Reticulated (young) platelet measurement 50 $35 $143
Ct scan of chest with contrast 47 $52 $821
Nuclear medicine study from skull base to mid-thigh with ct scan 45 $1,186 $4,802
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries 44 $91 $657
Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l 44 $135 $500
CT scan of abdomen and pelvis with contrast 41 $185 $1,067
Unclassified drugs 39 $1 $8
Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion 32 $16 $94
New patient office visit, complex (60-74 min) 28 $170 $709
CT scan of chest, without contrast 24 $47 $686
Irrigation of implanted venous access drug delivery device 18 $18 $114
Microscopic examination for white blood cells with manual cell count 17 $4 $22
Complete blood count (CBC), automated 17 $6 $34
New patient office visit (45-59 min) 17 $127 $565
Infusion, normal saline solution , 1000 cc 14 $2 $19
Ct scan of abdomen and pelvis without contrast 11 $80 $560
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
32.3% high complexity
63.8% medium
3.9% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$2,400
Total received (2018-2024)
Avg $400/year across 6 years
Top 27% in TX for internal medicine
48
Companies
99
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,214 (92.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$186 (7.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$752
2023
$803
2022
$607
2021
$24
2019
$113
2018
$100

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$192
Novartis Pharmaceuticals Corporation
$173
Janssen Biotech, Inc.
$153
Apellis Pharmaceuticals, Inc.
$143
Incyte Corporation
$114
PFIZER INC.
$90
EMD Serono, Inc.
$86
Bayer HealthCare Pharmaceuticals Inc.
$78
JAZZ PHARMACEUTICALS INC.
$62
Merck Sharp & Dohme LLC
$58
Daiichi Sankyo Inc.
$56
GENZYME CORPORATION
$55
Takeda Pharmaceuticals U.S.A., Inc.
$55
ABBVIE INC.
$51
Sobi, Inc
$51
Mirati Therapeutics, Inc.
$51
Gilead Sciences, Inc.
$51
Seagen Inc.
$50
BeiGene USA, Inc.
$49
Rigel Pharmaceuticals, Inc.
$46
Eisai Inc.
$45
Boehringer Ingelheim Pharmaceuticals, Inc.
$42
AstraZeneca Pharmaceuticals LP
$42
MorphoSys, US Inc.
$40
PUMA BIOTECHNOLOGY, INC.
$36
Sirtex Medical Inc
$36
Celgene Corporation
$34
CTI BioPharma Corp.
$33
PharmaEssentia USA Corporation
$32
Myovant Sciences Inc.
$28
TerSera Therapeutics LLC
$28
Genentech USA, Inc.
$27
SOBI, INC
$26
Deciphera Pharmaceuticals Inc.
$26
Bayer Healthcare Pharmaceuticals Inc.
$23
Stemline Therapeutics Inc.
$23
TAIHO ONCOLOGY, INC.
$22
Karyopharm Therapeutics Inc.
$21
Puma Biotechnology, Inc.
$20
Alexion Pharmaceuticals, Inc.
$20
Pharmacosmos Therapeutics Inc.
$19
Tactile Systems Technology Inc
$19
E.R. Squibb & Sons, L.L.C.
$19
Exelixis Inc.
$18
Amgen Inc.
$16
ARRAY BIOPHARMA INC
$15
Alnylam Pharmaceuticals Inc.
$14
Myriad Genetic Laboratories, Inc.
$12
Top 3 companies account for 21.6% of total payments
Associated products mentioned in payments ›
ALUNBRIG · Alecensa · BAVENCIO · BESPONSA · BESREMI · BRUKINSA · CABOMETYX · DARZALEX · DOPTELET · Doptelet · ELAHERE · ENJAYMO · EPKINLY · ERLEADA · Empaveli · Enhertu · Fabhalta · Flexitouch Plus · GAZYVA · GILOTRIF · GIVLAARI · IBRANCE · IMBRUVICA · IMFINZI · JAKAFI · KEYTRUDA · KISQALI · KRAZATI · LONSURF · LUMAKRAS · Lenvima · MEKINIST · MONJUVI · MONOFERRIC · NERLYNX · NINLARO · OPDIVO · ORGOVYX · Orserdu · PIQRAY · PROMACTA · QINLOCK · REBLOZYL · RYBREVANT · Rezlidhia · SCEMBLIX · SIR-Spheres Microspheres · Stivarga · TUKYSA · Trodelvy · ULTOMIRIS · VERZENIO · Vonjo · XALKORI · XPOVIO · XTANDI · Xofigo · ZEPZELCA · Zoladex · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (92%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $3 per 100 Medicare services performed
Looking for an internal medicine specialist in Webster?
Compare internal medicine physicians in the Webster area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians within 10 mi
1,900
Per 100K population
39.9
County median income
$73,104
Nearest hospital
HCA HOUSTON HEALTHCARE CLEAR LAKE
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Lakhani is a mixed practice specialist, with above-average Medicare volume (top 1% in TX), with low-engagement industry engagement, with 15 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Lakhani experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Lakhani performed 23,460 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lakhani receive payments from pharmaceutical companies?
Yes. Dr. Lakhani received a total of $2,400 from 48 companies across 99 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lakhani's costs compare to other internal medicine physicians in Webster?
Dr. Lakhani's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lakhani) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →